Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Mar 16, 2021 $50.02 -4.10% $52.16 X 95.90% 1
Mar 16, 2021 Bullish $52.16 X 0
Mar 16, 2021 Bullish $52.16 X 0
Mar 9, 2021 Bullish $52.05 X 1
JS JS Pro
Mar 4, 2021 $47.96 +7.82% $44.48 X 92.18% 1
Mar 4, 2021 Bullish $44.48 X 0
JS JS Pro
Feb 23, 2021 $50.70 -3.19% $52.37 X 96.81% 1
Zwj Ephram Zwj Ephram @ZwjEphram.200868
Feb 23, 2021 $75.00 +43.21% $52.37 X 56.79% 0
JS JS Pro
Feb 5, 2021 $55.45 +23.77% $44.80 X 76.23% 1
Jhon Giraldo Jhon Giraldo @JhonGiraldo.200310
Feb 5, 2021 Bearish $44.80 X 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE